Our client wanted to understand the clinical and economic evidence requirements that drive payer dec...
Read moreOur client required focused payer value messages for their orphan drug as payers were not recognizin...
Read moreOur client wanted to gain a better understanding of current and forthcoming policy measures affectin...
Read moreDevelopment and submission of payer communication materials and pricing and reimbursement dossiers f...
Read moreOncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore joint scientific consultations; what they mean and why they are important to manufacturer...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read moreWe summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...
Read moreFimea program aims to standardise the initiation of assessment which are currently different for out...
Read moreThe Project Orbis initiative is an international partnership between medicines regulators in the UK,...
Read more